{"id":158400,"date":"2023-12-14T07:56:18","date_gmt":"2023-12-14T06:56:18","guid":{"rendered":"https:\/\/uniavisen.dk\/42-millioner-til-udvikling-af-ny-medicin-mod-autisme-og-skizofreni\/"},"modified":"2023-12-18T13:42:34","modified_gmt":"2023-12-18T12:42:34","slug":"dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia","status":"publish","type":"post","link":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/","title":{"rendered":"DKK 42 million to develop new drugs to treat autism and schizophrenia"},"content":{"rendered":"

Kristian Str\u00f8mgaard, who became a professor at the University of Copenhagen in 2006, is in particular drawn to high-risk research. Research, that is, where it can be difficult to achieve results.<\/p>\n

This is one of the reasons why Kristian Str\u00f8mgaard has chosen to get involved in the challenging research area of biomolecular condensates<\/em>. It is about understanding how proteins are organised in cells.<\/p>\n

The biomolecular condensates were first described by science in 2009. The proteins are part of a process in the cells that is vital to their functioning and development \u2013 and which can end up affecting our health.<\/p>\n

But they are also completely new opportunities, according to Kristian Str\u00f8mgaard:<\/p>\n

\u00bbDrugs work primarily on proteins, so when we know more about how the proteins condense, we don\u2019t have far to go before new drugs can be developed. Over the next three to five years, we will work on making medicine for diseases such as autism, schizophrenia and intellectual disability, all caused by mutations in the proteins that condense in our cells.\u00ab<\/p>\n

Kristian Str\u00f8mgaard and his colleagues have previously developed substances that can affect one of the most important proteins, PSD-95, so his group already has extensive experience in the area.<\/p>\n

At his Str\u00f8mgaard Lab research group at the Department of Drug Design and Pharmacology at the University of Copenhagen, they also hope that the substances developed can mitigate the harmful effects of blood clots in the brain. There is currently no effective medicine against them.
\n
\nWithin the last 12 months, Kristian Str\u00f8mgaard has received two major grants totalling DKK 42 million, each with its own purpose, but which together increase the likelihood that new drugs can be developed.<\/p>\n

\u00bbIt was fantastic, of course, to get all the funding, and we are all full of energy now at Str\u00f8mgaard Lab so that we can solve this task. If everything goes well over the next five years, we hope to be able to establish new drugs for treatments of a wide range of diseases in the brain,\u00ab says Kristian Str\u00f8mgaard.<\/p>\n

In December 2022, Kristian Str\u00f8mgaard got a DKK 20 million grant<\/a> from the Lundbeck Foundation for basic research into biomolecular condensates. The grant is aimed towards discoveries that help develop new medicine related to neurological disorders.<\/p>\n

In 2023, he also received a DKK 22 million grant<\/a> from the Bioinnovation Institute to make good on the various potentials from basic scientific discoveries that Str\u00f8mgaard Lab would make over the coming years.
\n
\nKristian Str\u00f8mgaard got the University of Copenhagen’s Innovation Award in 2021 and has met many people along the way. He graduated as a pharmacist in 1996 and has a PhD. in medicinal chemistry from 1999.<\/p>\n

He is now 53 years old and has been a track athlete. He continues to run and cycle, but no longer competitively.<\/p>\n

He has a wife and two children and has just moved from Roskilde to the Carlsberg Byen quarter in Copenhagen closer to his workplace.
\n
\nFor those who are particularly interested in biomedical research, there is a link to the Str\u00f8mgaard Lab here<\/a>.<\/p>\n

In 2023, two researchers received The Breakthrough Prize in Life Sciences for their research into biomolecular condensates. The two are Anthony A. Hyman<\/a> and Clifford P. Brangwynne<\/a>.<\/p>\n

It was the Novo Nordisk Foundation that set up the Bioinnovation Institute in 2017<\/a> with the purpose of being able to mature new scientific discoveries within pharmaceuticals and biotechnology to make them ready for commercialization.
\n<\/p>\n","protected":false},"excerpt":{"rendered":"

With two huge grants behind him, Professor Kristian Str\u00f8mgaard can now spend three to five years closely studying the development of proteins in brain cells.<\/p>\n","protected":false},"author":8,"featured_media":158132,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[3160],"tags":[],"class_list":["post-158400","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-people","expression-news_article"],"acf":[],"aioseo_notices":[],"yoast_head":"\nDKK 42 million to develop new drugs against autism and schizophrenia<\/title>\n<meta name=\"description\" content=\"With two huge grants behind him, Professor Kristian Str\u00f8mgaard can now spend three to five years closely studying the development of proteins in brain cells.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DKK 42 million to develop new drugs against autism and schizophrenia\" \/>\n<meta property=\"og:description\" content=\"With two huge grants behind him, Professor Kristian Str\u00f8mgaard can now spend three to five years closely studying the development of proteins in brain cells.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/\" \/>\n<meta property=\"og:site_name\" content=\"University Post\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/uniavis\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-14T06:56:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-18T12:42:34+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1056\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anders Fjeldberg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@Uniavisen\" \/>\n<meta name=\"twitter:site\" content=\"@Uniavisen\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Fjeldberg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/\"},\"author\":{\"name\":\"Anders Fjeldberg\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/#\\\/schema\\\/person\\\/e92ba15746694abe6835e7ad00240ca7\"},\"headline\":\"DKK 42 million to develop new drugs to treat autism and schizophrenia\",\"datePublished\":\"2023-12-14T06:56:18+00:00\",\"dateModified\":\"2023-12-18T12:42:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/\"},\"wordCount\":580,\"image\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/uniavisen.dk\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/kristianstroemgaard_facebook-1.jpg\",\"articleSection\":[\"People\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/\",\"url\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/\",\"name\":\"DKK 42 million to develop new drugs against autism and schizophrenia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/uniavisen.dk\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/kristianstroemgaard_facebook-1.jpg\",\"datePublished\":\"2023-12-14T06:56:18+00:00\",\"dateModified\":\"2023-12-18T12:42:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/#\\\/schema\\\/person\\\/e92ba15746694abe6835e7ad00240ca7\"},\"description\":\"With two huge grants behind him, Professor Kristian Str\u00f8mgaard can now spend three to five years closely studying the development of proteins in brain cells.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/uniavisen.dk\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/kristianstroemgaard_facebook-1.jpg\",\"contentUrl\":\"https:\\\/\\\/uniavisen.dk\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/kristianstroemgaard_facebook-1.jpg\",\"width\":2400,\"height\":1056},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DKK 42 million to develop new drugs to treat autism and schizophrenia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/#website\",\"url\":\"https:\\\/\\\/uniavisen.dk\\\/\",\"name\":\"University Post\",\"description\":\"Independent of management\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/uniavisen.dk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/#\\\/schema\\\/person\\\/e92ba15746694abe6835e7ad00240ca7\",\"name\":\"Anders Fjeldberg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dbd29cb1d1ebf4635c343a9e2606601d58f406394ebf2f41b2d976b72071e42f?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dbd29cb1d1ebf4635c343a9e2606601d58f406394ebf2f41b2d976b72071e42f?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dbd29cb1d1ebf4635c343a9e2606601d58f406394ebf2f41b2d976b72071e42f?s=96&d=identicon&r=g\",\"caption\":\"Anders Fjeldberg\"},\"url\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DKK 42 million to develop new drugs against autism and schizophrenia","description":"With two huge grants behind him, Professor Kristian Str\u00f8mgaard can now spend three to five years closely studying the development of proteins in brain cells.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/","og_locale":"en_US","og_type":"article","og_title":"DKK 42 million to develop new drugs against autism and schizophrenia","og_description":"With two huge grants behind him, Professor Kristian Str\u00f8mgaard can now spend three to five years closely studying the development of proteins in brain cells.","og_url":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/","og_site_name":"University Post","article_publisher":"https:\/\/www.facebook.com\/uniavis","article_published_time":"2023-12-14T06:56:18+00:00","article_modified_time":"2023-12-18T12:42:34+00:00","og_image":[{"width":2400,"height":1056,"url":"http:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook.jpg","type":"image\/jpeg"}],"author":"Anders Fjeldberg","twitter_card":"summary_large_image","twitter_image":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook.jpg","twitter_creator":"@Uniavisen","twitter_site":"@Uniavisen","twitter_misc":{"Written by":"Anders Fjeldberg","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/#article","isPartOf":{"@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/"},"author":{"name":"Anders Fjeldberg","@id":"https:\/\/uniavisen.dk\/#\/schema\/person\/e92ba15746694abe6835e7ad00240ca7"},"headline":"DKK 42 million to develop new drugs to treat autism and schizophrenia","datePublished":"2023-12-14T06:56:18+00:00","dateModified":"2023-12-18T12:42:34+00:00","mainEntityOfPage":{"@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/"},"wordCount":580,"image":{"@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/#primaryimage"},"thumbnailUrl":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook-1.jpg","articleSection":["People"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/","url":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/","name":"DKK 42 million to develop new drugs against autism and schizophrenia","isPartOf":{"@id":"https:\/\/uniavisen.dk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/#primaryimage"},"image":{"@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/#primaryimage"},"thumbnailUrl":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook-1.jpg","datePublished":"2023-12-14T06:56:18+00:00","dateModified":"2023-12-18T12:42:34+00:00","author":{"@id":"https:\/\/uniavisen.dk\/#\/schema\/person\/e92ba15746694abe6835e7ad00240ca7"},"description":"With two huge grants behind him, Professor Kristian Str\u00f8mgaard can now spend three to five years closely studying the development of proteins in brain cells.","breadcrumb":{"@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/#primaryimage","url":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook-1.jpg","contentUrl":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook-1.jpg","width":2400,"height":1056},{"@type":"BreadcrumbList","@id":"https:\/\/uniavisen.dk\/en\/dkk-42-million-to-develop-new-drugs-against-autism-and-schizophrenia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/uniavisen.dk\/en\/"},{"@type":"ListItem","position":2,"name":"DKK 42 million to develop new drugs to treat autism and schizophrenia"}]},{"@type":"WebSite","@id":"https:\/\/uniavisen.dk\/#website","url":"https:\/\/uniavisen.dk\/","name":"University Post","description":"Independent of management","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/uniavisen.dk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/uniavisen.dk\/#\/schema\/person\/e92ba15746694abe6835e7ad00240ca7","name":"Anders Fjeldberg","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/dbd29cb1d1ebf4635c343a9e2606601d58f406394ebf2f41b2d976b72071e42f?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dbd29cb1d1ebf4635c343a9e2606601d58f406394ebf2f41b2d976b72071e42f?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dbd29cb1d1ebf4635c343a9e2606601d58f406394ebf2f41b2d976b72071e42f?s=96&d=identicon&r=g","caption":"Anders Fjeldberg"},"url":"https:\/\/uniavisen.dk\/en\/author\/anders\/"}]}},"advancedCustomFields":{"expression":{"term_id":15,"name":"News Article","slug":"news_article","term_group":0,"term_taxonomy_id":15,"taxonomy":"expression","description":"","parent":0,"count":11493,"filter":"raw"},"enable_comments":true,"align_content":"alignleft","feature_color":"","article_updated":"","layout_group":[{"acf_fc_layout":"Headline","use_post_title":true,"headline":"","style":"default","highlighted_words":"","text_size":"small"},{"acf_fc_layout":"Image","image":{"ID":158129,"id":158129,"title":"Kristian Str\u00f8mgaard forsker i biomolekyl\u00e6re kondensater i Universitetsparken","filename":"kristianstroemgaard_web.jpg","filesize":368616,"url":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web.jpg","link":"https:\/\/uniavisen.dk\/en\/?attachment_id=158129","alt":"","author":"8","description":"","caption":"Kristian Str\u00f8mgaard forsker i biomolekyl\u00e6re kondensater, som de f\u00e6rreste m\u00e5ske har h\u00f8rt om, men det er et relativt nyt forskningsomr\u00e5de, der med dygtighed - og lidt held - kan kaste ny medicin af sig. Her st\u00e5r han i laboratoriet i Universitetsparken.","name":"kristian-stroemgaard_web","status":"inherit","uploaded_to":158117,"date":"2023-12-07 09:02:48","modified":"2025-10-17 07:47:22","menu_order":0,"mime_type":"image\/jpeg","type":"image","subtype":"jpeg","icon":"https:\/\/uniavisen.dk\/wp-includes\/images\/media\/default.png","width":2400,"height":1600,"sizes":{"thumbnail":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-150x150.jpg","thumbnail-width":150,"thumbnail-height":150,"medium":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-480x320.jpg","medium-width":480,"medium-height":320,"medium_large":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-768x512.jpg","medium_large-width":768,"medium_large-height":512,"large":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-1280x853.jpg","large-width":1280,"large-height":853,"1536x1536":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-1536x1024.jpg","1536x1536-width":1536,"1536x1536-height":1024,"2048x2048":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-2048x1365.jpg","2048x2048-width":2048,"2048x2048-height":1365,"featured-soft":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-290x193.jpg","featured-soft-width":290,"featured-soft-height":193,"featured-hard":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-290x180.jpg","featured-hard-width":290,"featured-hard-height":180,"narrow":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-700x467.jpg","narrow-width":700,"narrow-height":467,"extended":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_web-990x660.jpg","extended-width":990,"extended-height":660}},"style":"extended","text_placement":"metadata-below","image_link_url":"","image_link_title":"","caption_prefix":"","enable_alternative_caption":true,"alternative_caption":"Kristian Str\u00f8mgaard does research in \u2018biomolecular condensates\u2019: Not many people have heard of them, but it is a relatively new research area that, with skill and a bit of luck, could lead to new medicinal drugs. Here he is in the laboratory in the Universityparken buildings."},{"acf_fc_layout":"Standfirst","subject":"Innovation","text":"Professor Kristian Str\u00f8mgaard har modtaget to store bevillinger, der g\u00f8r det muligt for ham forske de n\u00e6ste tre til fem \u00e5r i, hvordan nogle s\u00e6rlige proteiner udvikler sig i vores celler i hjernen, og hvordan vi kan p\u00e5virke dem, s\u00e5 vi kan forblive raske. ","use_post_excerpt":true},{"acf_fc_layout":"Byline","is_author":true,"contributors":false},{"acf_fc_layout":"Headline","use_post_title":false,"headline":"Who is he?","style":"heavy","highlighted_words":"Who","text_size":"small"},{"acf_fc_layout":"Content","content":"<p>Kristian Str\u00f8mgaard, who became a professor at the University of Copenhagen in 2006, is in particular drawn to high-risk research. Research, that is, where it can be difficult to achieve results.<\/p>\n<p>This is one of the reasons why Kristian Str\u00f8mgaard has chosen to get involved in the challenging research area of <em>biomolecular condensates<\/em>. It is about understanding how proteins are organised in cells.<\/p>\n<p>The biomolecular condensates were first described by science in 2009. The proteins are part of a process in the cells that is vital to their functioning and development \u2013 and which can end up affecting our health.<\/p>\n<p>But they are also completely new opportunities, according to Kristian Str\u00f8mgaard:<\/p>\n<p>\u00bbDrugs work primarily on proteins, so when we know more about how the proteins condense, we don\u2019t have far to go before new drugs can be developed. Over the next three to five years, we will work on making medicine for diseases such as autism, schizophrenia and intellectual disability, all caused by mutations in the proteins that condense in our cells.\u00ab<\/p>\n<p>Kristian Str\u00f8mgaard and his colleagues have previously developed substances that can affect one of the most important proteins, PSD-95, so his group already has extensive experience in the area.<\/p>\n<p>At his Str\u00f8mgaard Lab research group at the Department of Drug Design and Pharmacology at the University of Copenhagen, they also hope that the substances developed can mitigate the harmful effects of blood clots in the brain. There is currently no effective medicine against them.<\/p>\n"},{"acf_fc_layout":"Headline","use_post_title":false,"headline":"Why am I reading about him now?","style":"heavy","highlighted_words":"Why","text_size":"small"},{"acf_fc_layout":"Content","content":"<p>Within the last 12 months, Kristian Str\u00f8mgaard has received two major grants totalling DKK 42 million, each with its own purpose, but which together increase the likelihood that new drugs can be developed.<\/p>\n<p>\u00bbIt was fantastic, of course, to get all the funding, and we are all full of energy now at Str\u00f8mgaard Lab so that we can solve this task. If everything goes well over the next five years, we hope to be able to establish new drugs for treatments of a wide range of diseases in the brain,\u00ab says Kristian Str\u00f8mgaard.<\/p>\n<p>In December 2022, Kristian Str\u00f8mgaard got a <a href=\"https:\/\/lundbeckfonden.com\/en\/proteiners-dynamik-syge-hjernes-biologi\">DKK 20 million grant<\/a> from the Lundbeck Foundation for basic research into biomolecular condensates. The grant is aimed towards discoveries that help develop new medicine related to neurological disorders.<\/p>\n<p>In 2023, he also received a <a href=\"https:\/\/bii.dk\/news\/neurophase\/\">DKK 22 million grant<\/a> from the Bioinnovation Institute to make good on the various potentials from basic scientific discoveries that Str\u00f8mgaard Lab would make over the coming years.<\/p>\n"},{"acf_fc_layout":"Headline","use_post_title":false,"headline":"Where have I heard about this person before?","style":"heavy","highlighted_words":"Where","text_size":"small"},{"acf_fc_layout":"Content","content":"<p>Kristian Str\u00f8mgaard got the University of Copenhagen’s Innovation Award in 2021 and has met many people along the way. He graduated as a pharmacist in 1996 and has a PhD. in medicinal chemistry from 1999.<\/p>\n<p>He is now 53 years old and has been a track athlete. He continues to run and cycle, but no longer competitively.<\/p>\n<p>He has a wife and two children and has just moved from Roskilde to the Carlsberg Byen quarter in Copenhagen closer to his workplace.<\/p>\n"},{"acf_fc_layout":"Headline","use_post_title":false,"headline":"What should I do now?","style":"heavy","highlighted_words":"I","text_size":"small"},{"acf_fc_layout":"Content","content":"<p>For those who are particularly interested in biomedical research, there is a link to the <a href=\"https:\/\/drug.ku.dk\/disciplines\/peptides-and-proteins\/stroemgaard-lab\/\">Str\u00f8mgaard Lab here<\/a>.<\/p>\n<p>In 2023, two researchers received The Breakthrough Prize in Life Sciences for their research into biomolecular condensates. The two are<a href=\"https:\/\/breakthroughprize.org\/Laureates\/2\/L3921\"> Anthony A. Hyman<\/a> and <a href=\"https:\/\/breakthroughprize.org\/Laureates\/2\/L3920\">Clifford P. Brangwynne<\/a>.<\/p>\n<p>It was the Novo Nordisk Foundation that <a href=\"https:\/\/novonordiskfonden.dk\/en\/news\/the-novo-nordisk-foundation-establishes-bioinnovation-institute-as-an-independent-foundation-to-provide-long-term-and-ambitious-support-for-innovation-in-life-sciences\/\">set up the Bioinnovation Institute in 2017<\/a> with the purpose of being able to mature new scientific discoveries within pharmaceuticals and biotechnology to make them ready for commercialization.<\/p>\n"},{"acf_fc_layout":"ArticleEnd"},{"acf_fc_layout":"Newsletter","lang_select":"en","identifier":"Newsletter","headline":"Get an email with our top stories","button_text":"Sign up here","class":""},{"acf_fc_layout":"OtherStories","headline":"","hand_picked_posts":false,"references":false,"category":false,"theme":false,"number_of_posts":"4","style":"default"}]},"taxonomyData":{"category":[{"term_id":3160,"name":"People","slug":"people","term_group":0,"term_taxonomy_id":3160,"taxonomy":"category","description":"","parent":0,"count":58,"filter":"raw"}],"post_tag":[],"post_format":[],"expression":[{"term_id":15,"name":"News Article","slug":"news_article","term_group":0,"term_taxonomy_id":15,"taxonomy":"expression","description":"","parent":0,"count":11493,"filter":"raw"}],"translation_priority":[{"term_id":5468,"name":"Optional","slug":"optional-en","term_group":0,"term_taxonomy_id":5468,"taxonomy":"translation_priority","description":"","parent":0,"count":674,"filter":"raw"}]},"featured_media_url":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2023\/12\/kristianstroemgaard_facebook-1-1280x563.jpg","_links":{"self":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/posts\/158400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/comments?post=158400"}],"version-history":[{"count":5,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/posts\/158400\/revisions"}],"predecessor-version":[{"id":158644,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/posts\/158400\/revisions\/158644"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/media\/158132"}],"wp:attachment":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/media?parent=158400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/categories?post=158400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/tags?post=158400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}